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Description of paper (100 characters) 
Epidemiology of imported malaria in London over fifteen years  
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
2 
 
Abstract 
Background 
We describe trends of malaria in London (2000-2014) in order to identify preventive 
opportunities and we estimated the cost of malaria admissions (2009/2010-2014/2015). 
Methods 
We identified all cases of malaria, resident in London, reported to the reference laboratory 
and obtained hospital admissions from Hospital Episode Statistics. 
Results 
The rate of malaria decreased (19.4[2001]-9.1[2014] per 100,000). Males were over-
represented (62%). Cases in older age groups increased overtime. The rate was highest 
amongst people of Black African ethnicity followed by Indian, Pakistani, Bangladeshi 
ethnicities combined (103.3 and 5.5 per 100,000, respectively). The primary reason for 
travel was visiting friends and relatives (VFR) in their country of origin (69%), mostly sub-
Saharan Africa (92%). The proportion of cases in VFRs increased (32%[2000]-50%[2014]) and 
those taking chemoprophylaxis decreased (36%[2000]-14%[2014]). The overall case fatality 
rate was 0.3%. We estimated the average healthcare cost of malaria admissions to be just 
over £1 million per year. 
Conclusion 
Our study highlighted that people of Black African ethnicity, travelling to sub-Saharan Africa 
to visit friends and relatives in their country of origin remain the most affected with also a 
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decline in chemoprophylaxis use.  Malaria awareness should focus on this group in order to 
have the biggest impact but may require new approaches.  
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1. Introduction 
In 2015, approximately 214 million cases of malaria and an estimated 438,000 deaths were 
reported worldwide, with an estimated fall in incidence of 37% between 2000 to 2015 [1]. 
Africa remains the most affected continent, with approximately 90% of all malaria cases and 
92% of malaria deaths (WHO).  
The UK has the second highest number of imported cases in Europe, following France [2]. In 
the last five years half of all cases reported in the UK occurred in London. This is likely to be 
a reflection of the ethnic diversity of the London population and also their travelling habits. 
In 2001, it was estimated that 8% of the total UK population were born abroad.  In 2014 the 
figure was over 14% and in London the estimate is above 36% [3].  
More than half of malaria cases are individuals travelling to visit friends and relatives in their 
country of origin. Cases occur in visitors and new entrants to the UK from abroad, as well as 
individuals travelling abroad from the UK for holiday or business. Changes in travel patterns 
and migration, as well as changes in the global epidemiology of malaria are likely to have an 
impact on the number of imported cases. However, the risk of malaria can be reduced by 
taking bite prevention measures, such as the use of bed nets and mosquito repellents, as 
well as taking appropriate chemoprophylaxis [4]. 
Under the Health Protection (Notification) Regulations 2010 malaria is a notifiable disease 
[5] and all positive specimens should be sent to the Public Health England (PHE) Malaria 
Reference Laboratory (MRL) for confirmation. Each specimen should be accompanied by a 
surveillance questionnaire that collects basic demographics, travel history and whether 
chemoprophylaxis was taken or not [6].  
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We aimed to describe the basic epidemiology of malaria in London between 2000 and 2014 
in order to identify vulnerable populations, as well as to provide a crude estimate of the cost 
of malaria admissions for the financial years 2009/2010 to 2014/2015.   The situation in 
London may mirror the situation in other global cities in non-endemic countries and could 
provide valuable information for malaria prevention.  
2. Methods 
2.1 Malaria reference laboratory data 
Data on malaria cases in the UK is collected by the PHE MRL housed at the London School of 
Hygiene & Tropical Medicine and managed by the PHE Travel and Migrant Health Section. 
This is the most complete dataset on malaria in the UK [7]. We conducted a cross-sectional 
study of the cases confirmed by the PHE MRL between 2000 and 2014 presumed to be 
resident within London. 
From 2013 onwards, missing data was supplemented where available, using HPZone 
(HPZone TM Infact Shipley, Yorkshire) which is an online case management tool that it is 
used by the health protection teams in England. Individuals with malaria that were on 
HPZone but not on the MRL data were added into a final dataset. 
The final dataset included information on: demographics (age, sex, ethnicity [only from 
2004], postcode, and local authority, country of birth and country of usual residence), 
clinical information (date of onset), travel information (reason for travel, travel destination 
and duration of travel), microbiological data (Plasmodium species), and whether 
chemoprophylaxis was taken or not.  
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Cases were classified according to reason for travel when provided. When missing, country 
of usual residence was used instead to classify cases into “travelled abroad from the UK” or 
“foreign visitors”. Where country of travel was missing, we used world region of travel.  
2.2 Hospital episode statistics 
Information on hospital admissions, length of stay by main speciality and age was obtained 
from the Hospital Episode Statistics
©
 (HES). This is a secured data warehouse managed by 
the Health and Social Care Information Centre that contains details of all National Health 
Service (NHS) admissions in England [8]. This included all the finished admissions episodes in 
residents in London admitted to hospital between 2000 and 2014 that mentioned malaria in 
any of the diagnosis fields. Therefore, admissions do not represent the number of patients, 
as a person may have more than one admission within the study period.  
2.3 Descriptive analysis 
We calculated the incidence per year using midyear population estimates for 2014 from the 
Office for National Statistics (ONS)  [9]. We mapped the rates for 2014 by local authority 
using ArcGIS
©
 V.10.2 [10]. We presented the demographics, type of travel and Plasmodium 
species of all cases regardless of whether they were foreign visitors or London residents 
travelling abroad from the UK.   We described the reason for travel, continent the case 
travelled to and the use of chemoprophylaxis only for cases that travelled abroad from the 
UK. We completed the descriptive analysis using Stata
©
 V13.1 [11] and we presented the 
data in five year cohorts.  
We allocated an Index of Mass Deprivation (IMD) 2015 to each case [12]. The English Indices 
of Deprivation 2015 are based on 37 separate indicators, organised across seven distinct 
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domains of deprivation (income; employment; health deprivation and disability; education, 
skills and training; crime; barriers to housing and services; and living environment) which are 
combined, using appropriate weights, to calculate the IMD 2015 [12]. The score represents 
an overall measure of multiple deprivation experienced by people living in an area and is 
calculated for every Lower Super Output Area (LSOA). Every LSOA in England is ranked 
according to its level of deprivation relative to that of other areas. In order to allocate an 
IMD to the cases the postcode of residence was first geocoded to LSOA [13];  using ArcGIS
©
 
V.10.2. An IMD score quintile was then allocated to each LSOA within our dataset. We 
plotted in a map the deprivation scores by LSOA and local authority. 
2.4 Cost analysis of hospital admissions for the financial years 2009/2010 to 2014/2015 
The NHS national tariff payment system [14] for each financial year between 2009/2010 to 
2014/2015 was used to estimate the crude cost of hospital admissions in London that had 
malaria mentioned in any of the diagnosis fields [Healthcare resource group (HRG) name, 
‘Malaria’; HRG code,  WA08Z ]. We calculated the average cost to the health care system per 
admission based on the number of admissions and the length of stay. We used the non-
elective spell tariff and we calculated an average cost for the six year period by dividing the 
overall cost by the number of years in the study. Assuming that all admissions came through 
the Accidents & Emergencies (A&E) department we also applied the A&E tariff (Category 1 
investigation with category 1-2 treatment) by calculating an average for the study period 
and applying it to each admission.  
3. Results  
3.1 Descriptive analysis of all malaria cases in London between 2010 and 2014 
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Between 2000 and 2014 a total of 15,473 cases of malaria were reported in London, whilst 
25,222 cases were reported in the UK. Overall, since 2000, the number of cases of malaria in 
London decreased, by 39% in 2014 compared with 2000 (Figure 1, Table 1). The incidence 
rate in 2014 in London was 9.1 per 100,000, compared with 2.5 per 100,000 in the UK 
(Incidence rate ratio [IRR] 3.6, Confidence interval [CI] 3.3; 4.0, p <0.0001) (Figure 1).  The 
rate of malaria in London decreased from 19.4 per 100,000 population in 2001, down to 9.1 
per 100,000 population in 2014 (IRR 2.1, CI 1.9; 2.3, p <0.0001).  
The median age of cases in 2000 and 2014 was 35 years (interquartile range [IQR], 24-46 
years), and cases were predominantly male (62%). The median age of cases in 2000 was 30 
years of age (interquartile range [IQR], 8-42 years)  and 39 years of age (IQR 25-50 years) in 
2014 (p <0.0001). A shift in age distribution of cases between 2000 and 2014 was observed, 
with an increase in cases occurring in 45-60 years and >60 years, and a decrease in cases 
aged <15 years, 15-29 years and 30-45 years (Table 1; Figure 2). 
 In 2014, 37% (291/779) of cases occurred in south London, with the highest rates observed 
in the following local authorities: Southwark, Lewisham and Greenwich (31/100,000, 
24/100,000, 21/100,000 population respectively) (Figure 3). Regarding the deprivation 
score, cases between 2000 and 2014 in London were predominantly in the most deprived 
quintiles 1 and 2 (41% [4,262/1,0259] and 35% [3,610/10,259], respectively). In Figure 4 we 
have plotted the areas in London that are most deprived.  
In London, the majority of malaria cases were due to P. falciparum (82%, 12,713/15,357), 
followed by P. vivax (10%, 1497/15,357). Almost all those infected with P. falciparum had 
visited sub-Saharan Africa (97%, 9927/10256), whilst those with P. vivax had predominantly 
visited the Indian sub-continent (77%, 877/1,141). We observed a strong seasonal trend, 
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with the number of cases each year peaking during the summer months (July to 
September), coinciding with the UK summer holiday. 
Ethnicity was routinely recorded for cases reported from 2004 onwards and was known for 
92% of cases in London between 2004 and 2014. The majority of cases were of African 
ethnicity (82%, 7,722/9,399), with a further 10% (999/9,399) of Indian, Pakistani or 
Bangladeshi ethnicity (Table 1). The rate of malaria in 2014 in individuals of African ethnicity 
was 103.3 per 100,000, compared with 5.5 per 100,000 in individuals of Indian, Pakistani 
and Bangladeshi descent combined (IRR 18.6, CI 14.2, 24.9; p <0.0001). 
The reason for travel was known for 57% (8,780) cases between 2000 and 2014. Of these, 
69% (6,052) were individuals visiting friends and relatives (VFR), 20.2% (1,774) were foreign 
visitors, 6% (524) were travelling on holiday and 3% (301) were travelling for business. 
Among the cases for which the reason for travel was known, VFR represented the highest 
increase in proportion from 57% (415/726) in 2000 to 75% (395/525) in 2014 (p<0.0001) 
which represented a minimum decrease in the crude number of cases. When we used the 
five year averages presented in Table 2, the increase remained significant for VFR (80% in 
2000-2004 to 90% in 2010-2014, p<0.0001). There was a significant decrease in the 
proportion of cases whose reason for travel was holidays (12% in 2000-2014 to 3.8% in 
2010-2014, p<0.05), the people who travel for business remained stable (4.8% 2000-2004 to 
4.9% 2010-2014, p>0.05).  
3.2 Descriptive analysis of cases of malaria that travelled abroad, London 2000 to 2014 
Out of the total number of cases reported in London between 2000 and 2014, 50% 
(7,728/15,473) travelled abroad (Table 2). The median duration of travel between 2005 and 
2014 was 28 days (IQR, 14-42 days) (Table 2). A total of 6,404 (92%) reported travelling to 
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sub-Saharan Africa, in particular Nigeria, and 394 (6%) reported travelling to the Indian sub-
continent. Travel destination remained largely stable other than a slight increase in the 
number of cases travelling to the Indian sub-continent was observed.  
Of those who travelled abroad from London, 23% of cases between 2000 and 2014 reported 
taking chemoprophylaxis (1,500/6,496). Amongst VFR, in 2000 the proportion who reported 
taking chemoprophylaxis was 36% (139/386) compared to 14% (44/312) in 2014 (p 0.005). 
Although it appears that the number of individuals taking chemoprophylaxis declined there 
is significant missing data and information regarding the appropriateness of 
chemoprophylaxis taken and whether individuals adhered to the regimen was unavailable.  
3.3 Descriptive analysis of deaths due to malaria reported in London between 2000 and 2014 
Since 2000, 44 deaths due to malaria were reported in London, with a case fatality rate 
(CFR) of 0.3% in all ages. Most of the malaria deaths (98%, 43/44) were infected with P. 
falciparum and one case was infected with P. vivax. The ages ranged between 6 and 70 
years, with a median age of 47 years. Five deaths occurred in children under the age of 16, 
with no deaths in children under five years. Males and females were equally affected, with 
48% of deaths in male cases. Most of the malaria deaths were in cases that had travelled 
abroad from the UK (81%, 30/37), with seven cases arriving in London (19%) either as 
visitors or new entrants. Only four individuals reported taking chemoprophylaxis. Out of the 
remaining individuals, 23 reported taking no prophylaxis and no information was available 
for 17. 
3.4 Descriptive analysis of admissions between 2000 and 2014 and economic costing of 
admissions reported by HES for the financial years 2009/2010 to 2014/2015 
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A total of 13,916 malaria hospital admissions were reported by HES between 2000 and 2014 
(Table 3). Overall, the total number of admissions fell between 2000 and 2014, and the 
average length of stay decreased (Table 3). The majority of admissions did not have a 
speciality listed. Admissions predominantly occurred in adults aged between 15 and 60 
years, and the shift in age distribution is observed between 2000 and 2014, with an increase 
in admissions in older age groups (Table 3).  
Between 2009/2010 and 2014/2015 the number of malaria admissions was over four and a 
half thousand. The average length of stay was two days. Overall, the crude estimate of cost 
was over £6 million and on average it was just over a £1 million per study year (Table 4) 
4. Discussion 
The results of this study are largely in accordance with previous findings for London [15] and 
with the national review of malaria [16].  This study showed that the rates of malaria in 
London have declined between 2000 and 2014. The reasons for the decline are unclear. 
Previous studies in the UK suggested a decline in malaria transmission in West Africa as a 
possible explanation [17]. In Amsterdam the decline in number of cases  observed up until 
2002 were attributed to a decrease in nonimmune patients [18]. However, this was followed 
by an increase in the Netherlands most notably since 2013 and mostly due to immigration of 
asylum seekers from the horn of Africa and among VFRs [19]. An increasing trend in malaria 
cases between 1973 and 2013 was also seen in the US, a country with a similar 
epidemiology to the UK where malaria affected mostly VFRs and  travellers to Africa, 
specifically Nigeria [20]. Increases in the US were mostly attributed to  inadequate use of 
appropriate prevention measures by travellers [20].  
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The epidemiological description of cases in London suggests that males were more likely to 
have malaria, with cases predominantly occurring in adults aged between 15 and 60 years, 
possibly reflecting UK travel patterns. The highest rates of malaria were among individuals 
of African descent followed by individuals of Indian, Pakistani and Bangladeshi descent 
combined. The majority of cases occurred in individuals travelling abroad from London, 
more specifically, travelling to visit friends and relatives in their country of origin. Although 
there was an overall downward trend, the proportion of cases amongst VFRs increased 
significantly during the study period although in absolute numbers they remained broadly 
similar. Within this group, the main region of travel was sub-Saharan Africa, and in particular 
Nigeria, Ghana and Sierra Leone. 
The highest burden of disease was amongst residents of south east London, particularly in 
Southwark, Lewisham and Greenwich. The geographical distribution of cases in London is 
likely explained by the ethnic background of the different London boroughs. People of West 
African heritage tend to concentrate in certain London boroughs. Using the IMD score, the 
majority of cases were found to be resident in local authorities with high levels of 
deprivation (quintiles 1 and 2). 
The number of cases peaked in July-September each year, in line with the UK school 
summer holiday when individuals are most likely to travel abroad. This also coincides with 
the high-transmission rainy season in West Africa. The majority of malaria cases were due to 
P. falciparum, and this reflects the fact that most cases travelled to sub-Saharan Africa.  
In recent years there has been a shift in the age distribution of cases, with an increase in 
older age groups (45-60 years). This was observed in both notifications and inpatient 
admissions. One possible explanation is that older individuals are less susceptive to 
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preventative messages if they have been born in a malaria endemic country and so may 
underestimate their risk compared with individuals born in the UK. In addition they are at 
higher risk of mortality. In support of this, the proportion of individuals born in endemic 
countries increased over the study period, particularly in people over 40 years old. However, 
completion rates for country of birth were poor (45%). Increases in visits abroad from 2000 
to 2015 were observed in people over 65 years of age, but no apparent increases in trends 
were seen in age groups 45-54 and 55-64 suggesting that these groups are not necessarily 
travelling more. Further work on the reasons for this shift in age distribution is required to 
better understand it.  
Only 15% of cases travelling abroad from London reported taking chemoprophylaxis. 
Furthermore, the proportion of cases that took appropriate chemoprophylaxis for the travel 
destination is likely to be lower. A study by Smith et al showed that use of 
chemoprophylaxis varied according to the geographical origin of the individual, with the 
lowest reported uptake in individuals from Africa and South Asia [21]. In addition, they 
reported that VFRs were less likely to report taking prophylaxis compared with other 
travellers.   A number of different reasons for not taking chemoprophylaxis have been 
described, including cost, low perception of personal risk, failure to access the drugs prior to 
travel, lack of knowledge and scepticism over the efficacy of the drugs. However, other 
reasons include: feelings of competence amongst VFRs in their ability to self-manage the 
disease and that of doctors and other health care workers in their country of origin to 
diagnose and treat malaria appropriately. Also there was a perceived poor confidence in 
physicians in their country of residence to treat illnesses related to overseas travel, and 
malaria when returning [22–24]. Similar findings were shown in a study exploring adherence 
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to malaria prevention guidelines by US residents of Nigerian origin [25].  Some studies 
looking into malaria perceptions and practices in VFRs suggest that the decisions about 
malaria prevention in this group are complex and that preventive measures based on a 
knowledge deficit approach e.g. raising awareness may not be sufficient to have an impact 
in behaviour [26]. One option is to provide subsidised malaria chemoprophylaxis to increase 
uptake, and the results of a modelling study suggests that this is a cost-effective policy for 
reducing imported malaria cases [27]. Conversely, a study undertaken in the UK evaluating 
this strategy failed to demonstrate an impact on malaria prevention. It also appears that the 
use of chemoprophylaxis has declined in this group but there was a high proportion of 
missing information on chemoprophylaxis so this should be interpreted with caution. The 
decline in the use of chemoprophylaxis could be further explored by looking at prescription 
data, as done by Guedes et al 2010 in Finland [29]. However, this could be challenging as a 
lot of them are likely to be private prescriptions. In addition, no information regarding bite 
prevention measures was available in this study. This is one of the key public health 
messages given to travellers and it would be of interest to evaluate this in the future.   
The number of deaths due to malaria has remained stable since 2000, with a CFR of 0.3%. 
Previous studies have shown that the mortality risk is higher in elderly individuals and 
tourists [30,31]. However, due to the small number of deaths in this study, no trends could 
be observed. 
The total number of admissions is lower compared with the total number of cases in the 
MRL dataset, as it only includes inpatients. Some hospitals do not routinely admit non-
severe malaria. However this dataset may overestimate the number of inpatients as it does 
not differentiate between readmissions of the same patient.   
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
15 
 
The crude cost of malaria in London has declined as cases have reduced however it still 
represents just over a million pounds per year to the NHS in inpatient costs. However, these 
costs do not take into account other healthcare costs including outpatient, and non-
healthcare community costs and costs to the individual and family so the actual cost may be 
more than this. As malaria is preventable, this is a cost that could be reduced. This highlights 
the importance of preventative messages and strategies that can specifically target the most 
affected groups in London.   
 
5. Limitations 
Firstly, in this study changes in travel behaviour of London residents have not been taken 
into account. Since 2000 there has been a 5.3% annual increase in individuals travelling to 
visit friends and relatives, resulting in an increasing potential for exposure [32]. Secondly, 
the number of cases of malaria reported here are likely to be an under-estimate of the true 
number of cases. A previous capture-recapture study estimated that only 62% of all cases in 
London were captured by the MRL, although completion rates are highest for p. falciparum 
malaria  [33]. Thirdly, the completeness of the data is likely to have been improved from 
2013 onwards [34]. However, it remains poor for some of the fields for the previous years. 
In addition other relevant information such as whether individuals followed bite prevention 
guidelines was not available.  
When interpreting the cost estimates, there are a number of factors than need to be 
considered. Firstly, the costs were estimated using national prices, and therefore the costs 
for London may differ compare to the rest of the country. In addition, this is just an estimate 
of the cost, and true cost may vary, for example different tariffs other than the national 
tariff may have been used. Furthermore, we considered all patients to be non-elective, and 
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this will over-estimate the cost for elective patients (although the number of elective 
patients for malaria is likely to be low). The A&E tariff applied to the admissions is likely to 
underestimate the cost for some of the cases as we only applied Category 1. Some 
admissions were likely to require a higher level of care while in A&E.  Additionally, the cost 
of different specialties was not considered, for example intensive care is likely to be more 
costly, and therefore this may underestimate the overall cost. However, the number of 
patients in these specialities was low. Finally, HES data only includes NHS admissions so 
patients treated privately or cases that did not required admission to hospital are not 
included.  
Despite these limitations the results are based on a large dataset over a 15 year period, 
which allows the possibility to observe trends, and changes over time.  
 
6. Conclusion 
 
Overall, the number of cases of malaria in London has declined since 2000. This is in line 
with a 37% decline in the global incidence of malaria in the same time period. The global 
decline is likely to be due to advances in malaria control in endemic countries [1]. Better 
control measures in endemic countries may have had an impact on the number of cases 
occurring in London [1]. This might be more important for VFRs who might benefit from 
improvements in control measures targeting the local population in endemic countries. 
However, it is unclear how this may actually occur and also it would not explain the 
increases seen in other places such as the US and the Netherlands or the fact that the 
overall decline of cases in VFRs in London has remain unchanged since 2000. VFRs, 
especially those travelling to Nigeria, remain the most affected with a significant decline in 
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the proportion of VFRs using chemoprophylaxis. However, due to missing data this needs to 
be interpreted with caution. 
In the majority of circumstances, malaria remains a preventable disease. Efforts should 
focus on ensuring that appropriate pre-travel advice is provided, including bite prevention, 
discussion around the benefits of chemoprophylaxis and prescription of appropriate 
chemoprophylaxis for the region of travel, particularly given the high costs demonstrated in 
this study as a result of malaria hospital admissions in London.  The reasons for the fall in 
the use of chemoprophylaxis need to be better understood and may require the exploration 
of new strategies in order to reach this group and to increase awareness about malaria.  
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Table 1. Characteristics of cases of malaria reported by the Public Health England 
malaria reference laboratory, London 2000-2014 
 
    2000-2004 2005-2009 2010-2014 
    n % n % n % 
Total 6277   5065   4131   
Age (years) 6203   5021   4125   
  <15  976 15.7 620 12.3 343 8.3 
  15-29 1546 24.9 1225 24.4 959 23.2 
  30-44 2291 36.9 1663 33.1 1265 30.7 
  45-60 1022 16.5 1128 22.5 1200 29.1 
  >60 368 5.9 385 7.7 358 8.7 
Sex    5867   4872   4050   
Male 3566 60.8 2976 61.1 2635 65.1 
Country of birth 2982   2193   1820   
  
UK or non-endemic 
country 676 22.7 426 19.4 320 17.6 
  Malaria-endemic country 2306 77.3 1767 80.6 1500 82.4 
Ethnicity* 854   4655   6890   
  African 713 83.5 3639 84.6 3070 78.9 
  
Indian/Pakistani/ 
Bangladeshi 84 9.8 397 8.5 518 13.3 
  Other 57 6.7 319 6.9 302 7.8 
Plasmodium species 6221   5037   4099   
  P. Falciparum 5218 83.9 4238 84.1 3257 79.5 
  P. Vivax 521 8.4 441 8.8 535 13.1 
  Other 482 7.8 358 7.1 307 7.5 
Type of travel 3490   3091   2970   
  
Travelled abroad from 
the UK 2679 76.8 2490 80.6 2395 80.6 
  Foreign visitors 811 23.2 601 19.4 575 19.4 
Deprivation quintile 3358   3437   3464   
  1 (Most deprived) 1490 44.4 1443 42.0 1329 38.4 
  2 1134 33.8 1208 35.1 1268 36.6 
  3 477 14.2 540 15.7 559 16.1 
  4 184 5.5 174 5.1 229 6.6 
  5 (Least deprived) 73 2.2 72 2.1 79 2.3 
*Only collected routinely from 2004 onwards           
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Table 2. Characteristics of cases reported by the malaria reference laboratory that 
travelled abroad, London 2000-2014 
 
    2000-2004 2005-2009 2010-2014 
    n % n % n % 
Total (travelled abroad from 
the UK) 2741   2551   2436   
Duration of travel (median 
[IQR])† - - 28 14-42 28 16-42 
Reason for travel 2690   2267   2049   
  VFR 2173 80.8 2033 89.7 1846 90.1 
  Holiday 323 12.0 123 5.4 78 3.8 
  Business 128 4.8 73 3.2 100 4.9 
  Other 66 2.5 38 1.7 25 1.2 
Continent of travel 2646   2434   2331   
  Africa 2440 92.2 2235 91.8 2130 91.4 
  Indian sub-continent 122 4.6 145 6.0 145 6.8 
  Other 84 3.2 54 2.2 54 1.8 
Chemoprophylaxis 2315   1852   1739   
  Yes  730 31.5 358 19.3 287 16.5 
  No 1585 68.5 1494 80.8 1452 83.5 
†Data for duration of travel for 2000-2004 was 
unavailable.         
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Table 3. Total admissions, average length of stay, treatment specialty and age of 
malaria admissions reported by the Hospital Episode Statistics, London 2000-2014 
 
    2000-2004 2005-2009 2010-2014 
    n % n % n % 
Total number of 
admissions 5351   4732   3833   
Average length of 
stay 3.0   2.1   2.0   
Main Speciality             
  
Critical care 
medicine 0 0 37 0.8 33 0.9 
  Infectious diseases 1,073 20.1 364 7.7 239 6.2 
  Tropical medicine 0 0 146 3.1 103 2.7 
  Other 4,278 79.9 4,185 88.4 3,458 90.2 
Age (years)             
  <15  929 17.4 575 12.2 353 9.2 
  15-29 1255 23.5 1119 23.6 825 21.5 
  30-44 1957 36.6 1608 34.0 1205 31.4 
  45-60 852 15.9 1053 22.3 1127 29.4 
  >60 356 6.7 377 8.0 323 8.4 
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Table 4. Number of admissions, length of stay (in days) and overall cost and average 
cost per financial year of malaria admissions reported by the Hospital Episode 
Statistics, London 2009/10-2014/15 
 
Financial 
 year 
Number of 
admissions 
Average length 
of stay (days) Crude cost 
Crude cost per 
financial  year 
2009/10-
2014/15 4,606 2.0 £6,330,793 £1,055,132 
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Figure 1. Total number of cases and rates per 100,000 population of malaria by year 
in London, 2000 -2014 
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Figure 2. Age and sex distribution of malaria cases by five-year period, London 
2000-2014 
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Figure 3. Malaria rates per 100,000 population by local authority of residence and by 
ward for the three local authorities with the highest rates (Southwark, Lewisham and 
Greenwich), London 2014 
 
 
List of local authorities in London presented in order from the highest to the lowest 
rate of Malaria per 100,000 population in 2014 Southwark, Lewisham, Greenwich, 
Hackney, Barking and Dagenham, Camden, Croydon, Lambeth, Brent, Newham, 
Hammersmith and Fulham, Merton, Bexley, Enfield, Kensington and Chelsea, 
Hillingdon, Barnet, Wandsworth, Redbridge, Sutton, Haringey, Westminster, 
Islington, Waltham Forest, Harrow, Hounslow, Tower Hamlets, Ealing, Bromley, 
Havering, Richmond upon Thames, Kingston upon Thames and City of London 
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Figure 4. 2015 IMD scores by quintile, plotted by LSOA and local authority in 
London.  
 
